Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
22%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
PPH
26
HOLDINGS
52%
ALSO IN XPH
XPH
40
HOLDINGS
30%
ALSO IN PPH
SECTOR DRIFT (PPH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 11.6% | 3.8% | 3.8% |
|
MERCK & CO. INC. | 6.0% | 3.5% | 3.5% |
|
PFIZER INC | 4.5% | 3.3% | 3.3% |
|
ELI LILLY & CO | 17.8% | 3.1% | 3.1% |
|
BRISTOL-MYERS SQUIBB CO | 4.2% | 3.1% | 3.1% |
PPH Overweight Relative to XPH
|
ELI LILLY & CO | 14.7% |
 |
NOVARTIS AG-ADR | 7.7% |
|
JOHNSON & JOHNSON | 7.7% |
 |
NOVO-NORDISK A/S-SPONS ADR | 5.9% |
|
ABBVIE INC | 5.2% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.9% |
|
MCKESSON CORP | 4.5% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.5% |
 |
SANOFI-AVENTIS-ADR | 4.3% |
|
CENCORA INC | 3.9% |
PPH Underweight Relative to XPH
|
TARSUS PHARMACEUTICALS, INC. | -4.0% |
|
ELANCO ANIMAL HEALTH, INC. | -3.9% |
|
ROYALTY PHARMA PLC CLASS A | -3.6% |
|
CORCEPT THERAPEUTICS INC | -3.4% |
|
AXSOME THERAPEUTICS, INC. | -3.4% |
|
ORGANON & CO. | -3.4% |
 |
JAZZ PHARMACEUTICALS PLC | -3.3% |
|
BIOSANTE PHARMACEUTICALS INC | -3.2% |
|
VIATRIS, INC. | -3.0% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.7% |